Sphere Bio’s Post

What if your in vitro models provided the consistency and scalability needed in drug discovery? At #SLAS2025, our expert speaker lineup will discuss how our consistent and scalable human iPSC-derived ioCells are redefining drug discovery workflows. But you don’t need to be there to start exploring the possibilities. 🎥 Watch this short video to understand opti-ox™, the deterministic cell programming technology behind ioCells, converting entire cultures consistently and rapidly into a defined cell type. https://hubs.ly/Q032YT2d0 🎥 Discover how ioCells are accelerating drug discovery with expert insights from Charles River Laboratories. https://hubs.ly/Q032YT7M0 If you are at SLAS, join us on January 28th to see the data and hear the stories from those using these cells to overcome traditional bottlenecks. #research #DrugDiscovery #StemCells #DiseaseModelling #CRISPRscreening #optiox #ioCells #SLAS2025 #CNS #NeuroDegeneration #MEA #incucyte, Axion BioSystems, Sartorius, Timothy Smith, Malika Bsibsi, Austin Passaro, Cicely Schramm

In his recent article featured in Biocompare, our Director of Strategy and Product Marketing, Boris Aleynik, explores the critical manufacturing challenges in cell therapy and how technologies like real-time monitoring and CRISPR are streamlining processes and driving innovation. Cell therapies continue to face significant hurdles in scalability, consistency and cost, but our team is dedicated to making personalized medicine more affordable and accessible. Learn more about how these advancements are unlocking the potential of #celltherapy: https://bit.ly/4eMfrFy

How does Newcells keep innovating and improving In Vitro models and why? 💭 We sat down with Dr Mike Nicholds, CEO at Newcells, to pick his brain. Join the conversation by letting us know your thoughts in the comments. Read the full interview with Mike here: https://lnkd.in/gbJNbcNf #Newcells #InVitro #Biotech #PredictiveModels #DrugDiscovery

Join Vernal Biosciences to explore 🚀 #mrna #LNP in your #drugdevelopment 💉 🧪 🧬 journey. Learn how we can improve #speedtoclinic 📊 and lower #cogs 📉 .

Check out mRNA superstars Vernal Biosciences by registering for this exciting webinar!

Missed our recent webinar? Watch the 20 minutes recording🎥👇 to discover how Beacon® System is transforming Real-Time Single Cell Multiomics research. Dr. Vikram Devgan dives deep into how this cutting-edge technology accelerates the development of life-changing therapies. https://hubs.ly/Q02KmpFd0

𝐑𝐚𝐢𝐬𝐢𝐧𝐠 𝐭𝐡𝐞 𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝 𝐢𝐧 𝐀𝐧𝐭𝐢𝐛𝐨𝐝𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 This recent paper by Richard Kahn on antibody characterization highlights a critical challenge in biomedical research. At Cell Surface Bio, we’re tackling this by producing only recombinant antibodies and rigorously testing each one for off-target effects. We also test every antibody for applications like flow cytometry and immunofluorescence. If we say an antibody is validated for an application, we’ll show you the data to back it up!   We believe that with better tools, comes better science. Let’s work together to elevate the standards in antibody research and drive reproducibility across the field. 🌟🔬   https://lnkd.in/eRA-_E-F https://lnkd.in/e6HkuSPk #Biotech #Antibodies #Reproducibility #Innovation

𝐒𝐔𝐓𝐃 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐓𝐫𝐚𝐧𝐬𝐟𝐞𝐫 𝐎𝐟𝐟𝐢𝐜𝐞 In the race to advance personalised medicine for cancer and complex diseases, researchers rely on single-cell analysis to uncover hidden genetic clues. However, traditional cell sorting methods have a major flaw: their technology damages cells, limiting their value. With the rise in fragile cell woes, the CellWave story unfolds. Associate Professor Ye Ai from the Engineering Product Development pillar and CellWave's CEO, Robert Fu, leveraged Ye Ai’s acoustic microfluidic technology to create a gentle, sound wave-based cell-sorting system. This innovation is a game-changer for cancer research, drug discovery, and beyond. Fast forward to today: their first-generation product has been validated by industry experts and launched in China, with plans to expand internationally. Are you ready to be part of the next big breakthrough? Let’s connect! 📩 Reach out: tto@sutd.edu.sg #SUTD #Innovation #TechTransfer #Licensing #Biotech #SuccessStory #CellWave #CancerResearch

Single Cell Discoveries is excited to share our latest video with Illumina, highlighting our collaboration and its impact on VectorY, an Amsterdam-based Biotech company. By combining Illumina's NovaSeqX Plus with our expertise, we deliver rapid, transformative results. Check the video and see how our cutting-edge solutions can accelerate your research into breakthroughs!

🔬 Join Proteintech Group upcoming webinar on addressing the reproducibility crisis and advancing research through effective antibody characterization!🧪 Riham Ayoubi, Director of Operations at the YCharOS project, will share her expertise and practical tips for ensuring the #reliability and #reproducibility of your research. 📅 Register now: https://lnkd.in/e-KvND9v In this webinar, Dr. Ayoubi will cover: *The critical role of antibody characterization in overcoming reproducibility challenges. *YCharOS’s mission and platform for enhancing antibody validation. *Best practices and conditions for characterization in applications such as #westernblot, #immunoprecipitation, and #immunofluorescence. *Key challenges and limitations faced in #antibody characterization. Don’t miss this opportunity to learn from a leading expert and improve the reproducibility of your research.